[Debate: Preventive coronary intervention for vulnerable plaque. The clinical cardiologist's approach].
作者信息
Fernández-Olmo Rosa
机构信息
Servicio de Cardiología, Hospital Universitario de Jaén, Jaén, España Servicio de Cardiología Hospital Universitario de Jaén Jaén Españ.
出版信息
REC Interv Cardiol. 2024 Oct 16;7(1):51-53. doi: 10.24875/RECIC.M24000486. eCollection 2025 Jan-Mar.
Abstract
摘要
相似文献
1
[Debate: Preventive coronary intervention for vulnerable plaque. The clinical cardiologist's approach].[辩论：易损斑块的预防性冠状动脉介入治疗。临床心脏病专家的方法]
REC Interv Cardiol. 2024 Oct 16;7(1):51-53. doi: 10.24875/RECIC.M24000486. eCollection 2025 Jan-Mar.
2
[Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist's approach].[辩论：易损斑块的预防性冠状动脉介入治疗。介入心脏病学家的方法]
REC Interv Cardiol. 2024 Oct 16;7(1):54-56. doi: 10.24875/RECIC.M24000485. eCollection 2025 Jan-Mar.
3
Cardiologist's exposure to radiation in cath lab measured with Instadosedosimeter.使用即时剂量仪测量心脏科医生在导管室的辐射暴露情况。
J Radiol Prot. 2023 Feb 17;43(1). doi: 10.1088/1361-6498/acb82b.
4
Diversion of ST-elevation myocardial infarction patients for primary angioplasty based on wireless prehospital 12-lead electrocardiographic transmission directly to the cardiologist's handheld computer: a progress report.基于无线院前12导联心电图直接传输至心脏病专家手持电脑的ST段抬高型心肌梗死患者直接进行冠状动脉介入治疗：进展报告
J Electrocardiol. 2005 Oct;38(4 Suppl):194-8. doi: 10.1016/j.jelectrocard.2005.06.035.
5
Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective.冠状动脉血运重建术后的降脂治疗：介入心脏病学家的观点。
Am J Cardiol. 1998 Apr 9;81(7A):55E-62E. doi: 10.1016/s0002-9149(98)00199-4.
6
[Debate. "Orbiting" around the management of stable angina. The interventional cardiologist's perspective].[辩论。围绕稳定型心绞痛的管理“盘旋”。介入心脏病学家的观点]
REC Interv Cardiol. 2024 Apr 17;6(3):235-237. doi: 10.24875/RECIC.M24000453. eCollection 2024 Jul-Sep.
7
[Debate. Asymptomatic severe aortic stenosis: when should we intervene? The interventional cardiologist's perspective].[辩论。无症状重度主动脉瓣狭窄：我们何时应进行干预？介入心脏病学家的观点]
REC Interv Cardiol. 2023 Nov 2;6(1):43-45. doi: 10.24875/RECIC.M23000419. eCollection 2024 Jan-Mar.
8
The impact of the distance from the interventional cardiologist's home to the hospital during off hours.非工作时间介入心脏病专家的家到医院的距离所产生的影响。
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):950-4. doi: 10.1002/ccd.25492. Epub 2014 Apr 16.
9
Revascularization of patients with coronary artery disease: the interventional cardiologist's perspective.冠心病患者的血运重建：介入心脏病专家的观点。
Ann Thorac Surg. 1997 Jun;63(6 Suppl):S23-7. doi: 10.1016/s0003-4975(97)00438-4.
10
Cardiac Computed Tomography Angiography in the Evaluation of Coronary Artery Disease: An Interventional Perspective.心脏计算机断层扫描血管造影在冠状动脉疾病评估中的应用：介入视角
J Soc Cardiovasc Angiogr Interv. 2024 Mar 26;3(3Part B):101301. doi: 10.1016/j.jscai.2024.101301. eCollection 2024 Mar.
本文引用的文献
1
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
2
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.预防性经皮冠状动脉介入治疗与单纯最佳药物治疗治疗易损动脉粥样硬化性冠状动脉斑块（PREVENT）：一项多中心、开放标签、随机对照试验。
Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8.
3
Atherosclerotic plaque stabilization and regression: a review of clinical evidence.动脉粥样硬化斑块的稳定和消退：临床证据回顾。
Nat Rev Cardiol. 2024 Jul;21(7):487-497. doi: 10.1038/s41569-023-00979-8. Epub 2024 Jan 4.
4
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.依洛尤单抗与家族性高胆固醇血症无症状患者的冠状动脉粥样硬化：ARCHITECT 研究。
Circulation. 2023 May 9;147(19):1436-1443. doi: 10.1161/CIRCULATIONAHA.122.062557. Epub 2023 Apr 3.
5
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis.钠-葡萄糖协同转运蛋白 2 抑制剂对伴有可诱导性心肌缺血和多支非阻塞性冠状动脉狭窄的糖尿病患者冠状动脉纤维帽厚度和主要不良心血管事件的影响。
Cardiovasc Diabetol. 2023 Apr 1;22(1):80. doi: 10.1186/s12933-023-01814-7.
6
Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction.依洛尤单抗对心肌梗死后他汀类药物治疗患者的冠状动脉斑块表型和负担的影响。
JACC Cardiovasc Imaging. 2022 Jul;15(7):1308-1321. doi: 10.1016/j.jcmg.2022.03.002. Epub 2022 Mar 16.
7
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.依洛尤单抗联合高强度他汀治疗对急性心肌梗死患者冠状动脉粥样硬化的影响：PACMAN-AMI 随机临床试验。
JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218.
8
Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial.依泽替米贝在他汀类药物治疗基础上甘油三酯升高患者中对冠状动脉粥样硬化进展的影响：EVAPORATE 试验的最终结果。
Eur Heart J. 2020 Oct 21;41(40):3925-3932. doi: 10.1093/eurheartj/ehaa652.
9
Vulnerable plaques and patients: state-of-the-art.易损斑块与患者：现状分析。
Eur Heart J. 2020 Aug 14;41(31):2997-3004. doi: 10.1093/eurheartj/ehaa227.
10
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.秋水仙碱治疗急性冠状动脉综合征患者及稳定斑块：一项 CT 冠状动脉造影研究。
JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):305-316. doi: 10.1016/j.jcmg.2017.08.013. Epub 2017 Oct 18.
Zotero 插件